Efficacy and tolerability of folfirinox in treatment of advanced pancreatic cancer patients / Haider Yousif Hameed Shukur ; Supervised Ehsan Gamal Eldin Elghonemy , Hanan Selim Mosalem , Amr Yehia Sakr
Material type: TextLanguage: English Publication details: Cairo : Haider Yousif Hameed Shukur , 2013Description: 149 P. : charts ; 25cmOther title:- فعالية و قابلية تحمل علاج فولفيرينوكس فى علاج حالات أورام البنكرياس المتقدم و المنتشر [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.23.Ph.D.2013.Ha.E (Browse shelf(Opens below)) | Not for loan | 01010110061788000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.23.Ph.D.2013.Ha.E (Browse shelf(Opens below)) | 61788.CD | Not for loan | 01020110061788000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Oncology-Clinical
In compares of FOLFIRINOX to Gemciabine group according to treatment line, we find that the ORR to FOLFIRINOX was 45% versus 10% in Gemcitabine arm also overall survival was 11 months versus 7 months although the toxicity of this protocol was greater than Gemcitabine, but all was manageable and tolerable
Issued also as CD
There are no comments on this title.